ExLibris header image
SFX Logo
Title: Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Zhu, Xi yr:2015


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Tang L, X. "Investigating the optimal size of anticancer nanomedicine." Proceedings of the National Academy of Sciences of the United States of America 111.43 (2014): 15344-9. Link to Full Text for this item Link to SFX for this item
2. Karachaliou, Niki G. "Genetics and biomarkers in personalisation of lung cancer treatment." Lancet (London, England) 382.9893 (2013): 720-731. Link to SFX for this item
3. Ganguli, A. "The impact of second-line agents on patients' health-related quality of life in the treatment for non-small cell lung cancer: a systematic review." Quality of life research 22.5 (2012): 1015-1026. Link to SFX for this item
4. Tagami, T. "Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery." International journal of pharmaceutics 422.1-2 (2012): 280-289. Link to SFX for this item
5. Shi, J. "Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation." Accounts of chemical research 44.10 (2011): 1123-34. Link to Full Text for this item Link to SFX for this item
6. Shankaran, H. "Model-Based Analysis of HER Activation in Cells Co-Expressing EGFR, HER2 and HER3." PLoS Computational Biology 9.8 (2013). Link to Full Text for this item Link to SFX for this item
7. Hensing, Thomas A. "Molecular biomarkers for future screening of lung cancer." Journal of surgical oncology 108.5 (2013): 327-333. Link to Full Text for this item Link to SFX for this item
8. Leighl, N B. "Treatment paradigms for patients with metastatic non-small-cell lung cancer: first-, second-, and third-line." Current oncology 19.Suppl 1 (2012): -8. Link to Full Text for this item Link to SFX for this item
9. kamaly, N. "targeted polymeric therapeutic nanoparticles: design, development and clinical translation." Chemical Society reviews 41.7 (2012): 2971-3010. Link to Full Text for this item Link to SFX for this item
10. Valencia, P. "Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles." Biomaterials 32.26 (2011): 6226-6233. Link to SFX for this item
11. Danhier, F. "To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?" Journal of controlled release 244.Part_A (2016): 108-121. Link to SFX for this item
12. Zhao, L. "Nanoparticle vaccines." Vaccine 32.3 (2013): 327-337. Link to SFX for this item
13. Liu, C. "The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles." Biomaterials 34.10 (2013): 2547-2564. Link to SFX for this item
14. Tomioka, K. "The Hearing Handicap Inventory for Elderly-Screening (HHIE-S) versus a single question: reliability, validity, and relations with quality of life measures in the elderly community, Japan." Quality of life research 22.5 (2012): 1151-1159. Link to SFX for this item
15. Arpawong, Steven E. "Posttraumatic Growth, Quality of Life, and Treatment Symptoms Among Cancer Chemotherapy Outpatients." Health psychology 32.4 (2012): 397-408. Link to SFX for this item
16. Kim, Y. "A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo." Biochemical and biophysical research communications 417.1 (2012): 330-334. Link to SFX for this item
17. Durand, J. "Erlotinib or gefitinib for non-small-cell lung cancer." The New England journal of medicine 364.24 (2011): 2367-2368. Link to SFX for this item
18. Ganti, Apar K. "Lung cancer management in 2010." Oncology 25.1 (2011): 64-73. Link to SFX for this item
19. Stephens, Philip J. "Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development." Cell 144.1 (2011): 27-40. Link to SFX for this item
20. Godin, B. "Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases." Trends in Pharmacological Sciences 31.5 (2010): 199-205. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.